Literature DB >> 24531463

Crystallographic study of FABP5 as an intracellular endocannabinoid transporter.

Benoît Sanson1, Tao Wang1, Jing Sun2, Liqun Wang2, Martin Kaczocha2, Iwao Ojima3, Dale Deutsch2, Huilin Li1.   

Abstract

In addition to binding intracellular fatty acids, fatty-acid-binding proteins (FABPs) have recently been reported to also transport the endocannabinoids anandamide (AEA) and 2-arachidonoylglycerol (2-AG), arachidonic acid derivatives that function as neurotransmitters and mediate a diverse set of physiological and psychological processes. To understand how the endocannabinoids bind to FABPs, the crystal structures of FABP5 in complex with AEA, 2-AG and the inhibitor BMS-309403 were determined. These ligands are shown to interact primarily with the substrate-binding pocket via hydrophobic interactions as well as a common hydrogen bond to the Tyr131 residue. This work advances our understanding of FABP5-endocannabinoid interactions and may be useful for future efforts in the development of small-molecule inhibitors to raise endocannabinoid levels.

Entities:  

Keywords:  domain swapping; intracellular endocannabinoid transportation; lipid-binding proteins

Mesh:

Substances:

Year:  2014        PMID: 24531463      PMCID: PMC3940194          DOI: 10.1107/S1399004713026795

Source DB:  PubMed          Journal:  Acta Crystallogr D Biol Crystallogr        ISSN: 0907-4449


  32 in total

1.  Molecular dynamics simulations of palmitate entry into the hydrophobic pocket of the fatty acid binding protein.

Authors:  Yossi Tsfadia; Ran Friedman; Jonathan Kadmon; Anna Selzer; Esther Nachliel; Menachem Gutman
Journal:  FEBS Lett       Date:  2007-02-28       Impact factor: 4.124

2.  Integration, scaling, space-group assignment and post-refinement.

Authors:  Wolfgang Kabsch
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-01-22

3.  Discovery and characterization of a highly selective FAAH inhibitor that reduces inflammatory pain.

Authors:  Kay Ahn; Douglas S Johnson; Mauro Mileni; David Beidler; Jonathan Z Long; Michele K McKinney; Eranthie Weerapana; Nalini Sadagopan; Marya Liimatta; Sarah E Smith; Scott Lazerwith; Cory Stiff; Satwik Kamtekar; Keshab Bhattacharya; Yanhua Zhang; Stephen Swaney; Keri Van Becelaere; Raymond C Stevens; Benjamin F Cravatt
Journal:  Chem Biol       Date:  2009-04-24

4.  A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol.

Authors:  Jacqueline L Blankman; Gabriel M Simon; Benjamin F Cravatt
Journal:  Chem Biol       Date:  2007-12

5.  Characterization of the drug binding specificity of rat liver fatty acid binding protein.

Authors:  Sara Chuang; Tony Velkov; James Horne; Christopher J H Porter; Martin J Scanlon
Journal:  J Med Chem       Date:  2008-06-06       Impact factor: 7.446

Review 6.  Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets.

Authors:  Masato Furuhashi; Gökhan S Hotamisligil
Journal:  Nat Rev Drug Discov       Date:  2008-06       Impact factor: 84.694

7.  Potent and selective biphenyl azole inhibitors of adipocyte fatty acid binding protein (aFABP).

Authors:  Richard Sulsky; David R Magnin; Yanting Huang; Ligaya Simpkins; Prakash Taunk; Manorama Patel; Yeheng Zhu; Terry R Stouch; Donna Bassolino-Klimas; Rex Parker; Thomas Harrity; Robert Stoffel; David S Taylor; Thomas B Lavoie; Kevin Kish; Bruce L Jacobson; Steven Sheriff; Leonard P Adam; William R Ewing; Jeffrey A Robl
Journal:  Bioorg Med Chem Lett       Date:  2006-12-21       Impact factor: 2.823

8.  Identification of intracellular carriers for the endocannabinoid anandamide.

Authors:  Martin Kaczocha; Sherrye T Glaser; Dale G Deutsch
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-23       Impact factor: 11.205

9.  REFMAC5 for the refinement of macromolecular crystal structures.

Authors:  Garib N Murshudov; Pavol Skubák; Andrey A Lebedev; Navraj S Pannu; Roberto A Steiner; Robert A Nicholls; Martyn D Winn; Fei Long; Alexei A Vagin
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2011-03-18

10.  MolProbity: all-atom structure validation for macromolecular crystallography.

Authors:  Vincent B Chen; W Bryan Arendall; Jeffrey J Headd; Daniel A Keedy; Robert M Immormino; Gary J Kapral; Laura W Murray; Jane S Richardson; David C Richardson
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-12-21
View more
  17 in total

1.  The Antinociceptive Agent SBFI-26 Binds to Anandamide Transporters FABP5 and FABP7 at Two Different Sites.

Authors:  Hao-Chi Hsu; Simon Tong; Yuchen Zhou; Matthew W Elmes; Su Yan; Martin Kaczocha; Dale G Deutsch; Robert C Rizzo; Iwao Ojima; Huilin Li
Journal:  Biochemistry       Date:  2017-06-28       Impact factor: 3.162

2.  Fatty acid-binding proteins (FABPs) are intracellular carriers for Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD).

Authors:  Matthew W Elmes; Martin Kaczocha; William T Berger; KwanNok Leung; Brian P Ralph; Liqun Wang; Joseph M Sweeney; Jeremy T Miyauchi; Stella E Tsirka; Iwao Ojima; Dale G Deutsch
Journal:  J Biol Chem       Date:  2015-02-09       Impact factor: 5.157

3.  Song-associated reward correlates with endocannabinoid-related gene expression in male European starlings (Sturnus vulgaris).

Authors:  Allison H Hahn; Devin P Merullo; Jeremy A Spool; Caroline S Angyal; Sharon A Stevenson; Lauren V Riters
Journal:  Neuroscience       Date:  2017-01-29       Impact factor: 3.590

Review 4.  Possible involvement of fatty acid binding proteins in psychiatric disorders.

Authors:  Yui Yamamoto; Yuji Owada
Journal:  Anat Sci Int       Date:  2021-02-18       Impact factor: 1.741

5.  Cytochrome c Can Form a Well-Defined Binding Pocket for Hydrocarbons.

Authors:  Levi J McClelland; Harmen B B Steele; Frank G Whitby; Tung-Chung Mou; David Holley; J B Alexander Ross; Stephen R Sprang; Bruce E Bowler
Journal:  J Am Chem Soc       Date:  2016-12-19       Impact factor: 15.419

6.  Fatty acid binding protein deletion suppresses inflammatory pain through endocannabinoid/N-acylethanolamine-dependent mechanisms.

Authors:  Martin Kaczocha; Sherrye T Glaser; Thomas Maher; Brendan Clavin; John Hamilton; Joseph O'Rourke; Mario Rebecchi; Michelino Puopolo; Yuji Owada; Panayotis K Thanos
Journal:  Mol Pain       Date:  2015-08-28       Impact factor: 3.395

7.  Inhibition of tumor growth by a newly-identified activator for epidermal fatty acid binding protein.

Authors:  Enyu Rao; Puja Singh; Xiuhong Zhai; Yan Li; Ganqian Zhu; Yuwen Zhang; Jiaqing Hao; Young-In Chi; Rhoderick E Brown; Margot P Cleary; Bing Li
Journal:  Oncotarget       Date:  2015-04-10

8.  A Personal Retrospective: Elevating Anandamide (AEA) by Targeting Fatty Acid Amide Hydrolase (FAAH) and the Fatty Acid Binding Proteins (FABPs).

Authors:  Dale G Deutsch
Journal:  Front Pharmacol       Date:  2016-10-13       Impact factor: 5.810

9.  Fatty-acid-binding protein inhibition produces analgesic effects through peripheral and central mechanisms.

Authors:  Xiaoxue Peng; Keith Studholme; Martha P Kanjiya; Jennifer Luk; Diane Bogdan; Matthew W Elmes; Gregory Carbonetti; Simon Tong; Yu-Han Gary Teng; Robert C Rizzo; Huilin Li; Dale G Deutsch; Iwao Ojima; Mario J Rebecchi; Michelino Puopolo; Martin Kaczocha
Journal:  Mol Pain       Date:  2017-01       Impact factor: 3.395

10.  Examination of the Addictive and Behavioral Properties of Fatty Acid-Binding Protein Inhibitor SBFI26.

Authors:  Panayotis K Thanos; Brendan H Clavin; John Hamilton; Joseph R O'Rourke; Thomas Maher; Christopher Koumas; Erick Miao; Jessenia Lankop; Aya Elhage; Samir Haj-Dahmane; Dale Deutsch; Martin Kaczocha
Journal:  Front Psychiatry       Date:  2016-04-05       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.